Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
Sign Up to like & getrecommendations! Published in 2022 at "Asian Cardiovascular and Thoracic Annals"
DOI: 10.1177/02184923221074414
Abstract: For 60 years, surgical myectomy has been the definitive treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM). Myectomy provides the opportunity to reverse heart failure symptoms in the vast majority of patient with low risk when… read more here.
Keywords: drug therapy; myectomy; surgical myectomy; therapy mavacamten ... See more keywords